ISX-Pix-1: A Potential Drug Target and Biomarker (G91464)

Target Name: ISX

NCBI ID: G91464

Content of Review Report on ISX Target / Biomarker

ISX

ISX-Pix-1: A Potential Drug Target and Biomarker

Introduction

The isocyanate drugs are a type of widely used analgesics. Their mechanism of action is to exert their analgesic effect by simulating the body's natural analgesic substance - dopamine receptors. However, excessive use or long-term use of these drugs may cause serious side effects, such as liver damage, kidney damage, and bowel cancer. Therefore, the search for new drug targets and biomarkers is of great clinical significance.

ISX-Pix-1: a potential drug target

ISX-Pix-1 is a compound derived from plants of the genus Asteracea, which has shown good analgesic effects in in vivo and in vitro experiments. Its mechanism of action is by simulating dopamine receptors, reducing the transmission of pain signals and reducing the excitability of neurons, thereby exerting its analgesic effect. At the same time, ISX-Pix-1 can also improve pain tolerance and relieve pain by regulating neurotransmitter levels in the nervous system.

The pharmacodynamic properties of ISX-Pix-1 suggest that it has potential as an analgesic drug. Although there are currently no clinical studies on ISX-Pix-1, based on its good analgesic effect and pharmacodynamic properties, ISX-Pix-1 is expected to become a class of analgesic drug target in the future.

Biological properties of ISX-Pix-1

In the field of biology, ISX-Pix-1 is believed to have a variety of biological activities. First, ISX-Pix-1 can act as a neuroprotective agent by regulating neuronal growth and synaptic plasticity, promoting neuronal survival and apoptosis, thereby protecting neurons from oxidative stress and damage.

Secondly, ISX-Pix-1 has anti-inflammatory effects. Inflammatory response is one of the main pathogenesis mechanisms of many diseases, and ISX-Pix-1 can reduce the incidence of pain and relieve the degree of pain by reducing the inflammatory response of neurons.

In addition, ISX-Pix-1 has a sedative effect. By mimicking dopamine receptors, ISX-Pix-1 reduces neuronal excitability, thereby producing a sedative effect. This gives ISX-Pix-1 potential as a sedative in future drug studies.

Pharmacokinetic properties of ISX-Pix-1

In the field of pharmacokinetics, the pharmacokinetic properties of ISX-Pix-1 are demonstrated by good bioavailability and rapid drug clearance. After its oral administration, ISX-Pix-1 is rapidly absorbed in the body and reaches peak concentration within a short period of time. It is widely distributed in various tissues, but mainly concentrated in brain tissue and kidneys.

In addition, ISX-Pix-1 has a longer elimination half-life (t1/2), which is beneficial to maintaining the bioavailability of the drug. In the body, the main metabolites of ISX-Pix-1 are inactive metabolites, and only about 10% are excreted unchanged in the urine. This gives ISX-Pix-1 better pharmacokinetic stability.

Pharmacological significance of ISX-Pix-1

ISX-Pix-1, as a compound derived from plants of the genus Australopithecus, has a variety of biological activities. In the nervous system, ISX-Pix-1 can regulate neuronal growth and synaptic plasticity by mimicking dopamine receptors, promoting neuronal survival and apoptosis, thereby protecting neurons from oxidative stress and damage.

In terms of inflammatory response, ISX-Pix-1 can reduce the incidence of pain and relieve pain by reducing the inflammatory response of neurons. This gives ISX-Pix-1 potential as an analgesic drug in future drug studies.

In addition, ISX-Pix-1 also has anti-inflammatory effects by regulating neuronal growth and synaptic plasticity and reducing neuronal excitability, thereby producing anti-inflammatory effects. This gives ISX-Pix-1 potential as an anti-inflammatory drug in future drug studies.

Application prospects of ISX-Pix-1

In summary, ISX-Pix-1 has multiple biological activities, including analgesia, anti-inflammatory, and neuroprotective effects. Due to its good pharmacokinetic and pharmacodynamic properties, ISX-Pix-1 is expected to become a future class of analgesic drug target.

Protein Name: Intestine Specific Homeobox

Functions: Transcription factor that regulates gene expression in intestine. May participate in vitamin A metabolism most likely by regulating BCO1 expression in the intestine (By similarity)

The "ISX Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ISX comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets